Tyra Biosciences (TYRA) Retained Earnings (2020 - 2026)
Tyra Biosciences (TYRA) reported Retained Earnings of $107000.0 for Q1 2026, down 84.45% on a YoY basis from $688000.0 in Q1 2025, and down 72.77% quarter-over-quarter from $393000.0 in Q4 2025.
Tyra Biosciences (TYRA) Retained Earnings (2020 - 2026) Analysis & Trends
Tyra Biosciences has reported Retained Earnings for 7 years, with the latest figure at $107000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 84.45% year-over-year to $107000.0; the trailing twelve-month figure through Mar 2026 stood at $107000.0 (down 84.45% YoY), and the FY2025 full-year result was $393000.0, down 48.96% from the prior year.
- Retained Earnings for Q1 2026 stood at $107000.0, down from $393000.0 in the prior quarter.
- The five-year high for Retained Earnings was $1.8 million in Q3 2024, with the low at -$307.6 million in Q2 2025.
- Historically, Retained Earnings has averaged -$89.8 million across 5 years, with a median of -$82.8 million in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 172.0% — and 2024, when it jumped 101.23%.
- Tyra Biosciences' Retained Earnings stood at -$95.7 million in 2022, then sank by 72.24% to -$164.8 million in 2023, then jumped by 100.47% to $770000.0 in 2024, then slumped by 48.96% to $393000.0 in 2025, then sank by 72.77% to $107000.0 in 2026.
- The last three Retained Earnings figures came in at $107000.0 (Q1 2026), $393000.0 (Q4 2025), and $442000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -838.07 Mn |
| 10 | Tyra Biosciences | 1.67 Bn | 1.67 Bn | - | 107,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | 393,000.00 |
| Sep 30, 2025 | 442,000.00 |
| Jun 30, 2025 | -307.56 Mn |
| Mar 31, 2025 | 688,000.00 |
| Dec 31, 2024 | 770,000.00 |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | -201.72 Mn |
| Mar 31, 2024 | -183.02 Mn |
| Dec 31, 2023 | -164.83 Mn |
| Sep 30, 2023 | -142.00 Mn |
| Jun 30, 2023 | -120.85 Mn |
| Mar 31, 2023 | -107.58 Mn |
| Dec 31, 2022 | -95.70 Mn |
| Sep 30, 2022 | -82.80 Mn |
| Jun 30, 2022 | -70.29 Mn |
| Mar 31, 2022 | -55.20 Mn |
| Dec 31, 2021 | -40.37 Mn |
| Sep 30, 2021 | -30.44 Mn |
| Dec 31, 2020 | -14.08 Mn |